WCG Announces — Strategies that Inform Investigation Selection and Enhance Enrollment, Free Webinar, January 25, 2018

Share Article

Clinical trial operators have no choice but to contract with sites. But are they optimizing the opportunity to accelerate study start-up, reduce expenses, and avoid complications?

Strategies that Inform Investigation Selection and Enhance Enrollment
**WCG Free Webinar**
January 25, 2018 — 1:30 p.m. – 2:30 p.m. ET
http://info.fdanews.com/strategic-site-contracting

Clinical trial sponsors are worried about how much site contracts are going to cost, or if they’ll delay time to market.

It can be a headache to negotiate these contracts. There are budgets to adhere to, deadlines to make and it feels out of control. But it’s not. Sign-up for a webinar that’s not just a personal safety net, but a key to unlocking the secrets of world-class site contract negotiating.

Mark the calendar for a 60-minute session with two top contracting experts at the top of their game. They’re here to help negotiate and finalize contracts with sites to ensure that sponsors begin their next study holding all the cards: quick startup, decreased costs, and, most importantly, no unnecessary terms and conditions that cause hassles and delays.

Take a practical deep dive into contracting that will change the paradigm with how to deal with sites on these key issues and thorny negotiating points:

  •     Start-up dates, deadlines, and schedules
  •     Necessary and avoidable costs and expenses
  •     Air-tight provisions that avoid hassles and complications
  •     Enrolling patients to expedite trials and time to market
  •     Payment terms and conditions that meet budget
  •     And much more!

Don’t get caught short on site negotiation.

Meet the Presenters:
Brooke Millman and Suzanne Caruso of WCG. Ms. Caruso is Vice President , Clinical Solutions, at the WIRB Copernicus Group, responsible for WCG’s robust suite of transformational solutions to operational strategy regarding site contracting, focusing on making WCG’s pharma and CRO clients successful with innovative solutions that improve safety, boost data collection and accuracy, and accelerate time to market. Before joining WCG, she served as the associate director of clinical operations, oncology, for Novartis. Ms. Millman, JD, is Vice President of Consulting solutions for the WECG Copernicus Group, stragegically advising clients and CRO partners through the contract negotiating process, including investigator budgets. Most recently, Millman seved as Clinical Legal Director at a large CRO where she was responsible for client, vendor, and site contracting services.

Who Will Benefit:
This session is a must-attend for anyone negotiating site contracts, including professionals holding these job titles:

  •     Director, Associate Director, or Manager, Site Identification/Feasbility Leader
  •     Director, Associate Director, Manager, Site Contracting
  •     Legal counsel or General Counsel
  •     Vice President, Clinical Operations
  •     Site Manager
  •     Director, Therapeutics

Webinar Details:
Strategies that Inform Investigation Selection and Enhance Enrollment
**WCG Free Webinar**
January 25, 2018 — 1:30 p.m. – 2:30 p.m. ET
http://info.fdanews.com/strategic-site-contracting

Easy Ways to Register:
Online:     http://info.fdanews.com/strategic-site-contracting
By phone: 888-838-5578 or 703-538-7600

WIRB-Copernicus Group® (WCG):
The pioneer of independent ethical review, WCG continues to drive ingenuity in the clinical research space. Today, WCG’s solutions are built upon the foundation of ethical review, but have grown to include a suite of complementary services and technologies that expand the capabilities of the modern research professional. WCG delivers transformational solutions that stimulate growth, foster compliance, and maximize efficiency for those who perform clinical trials.

Share article on social media or email:

View article via:

Pdf Print

Contact Author

Michelle Butler
FDANEWS
+1 (703) 538-7665
Email >
FDAnews
Like >
Visit website